VAQTA 50 [iU]/mL

VAQTA 50 [iU]/mL is an inactivated hepatitis A vaccine designed for intramuscular administration. It is used to prevent hepatitis A virus infection, a serious liver disease. This vaccine is suitable for individuals at risk of exposure to the virus.

VAQTA 50 [iU]/mL is primarily used for the prevention of hepatitis A, a viral infection that can cause liver damage. It is often recommended for travelers to regions with high rates of hepatitis A, as well as for individuals with certain medical conditions or lifestyles that increase their risk of exposure. The vaccine works by stimulating the body's immune system to produce antibodies against the hepatitis A virus.

Common effects of VAQTA 50 [iU]/mL may include soreness, redness, or swelling at the injection site. Some individuals may also experience mild fever, headache, or fatigue following vaccination. These effects are usually temporary and resolve on their own within a few days.

VAQTA 50 [iU]/mL should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to inform your healthcare provider about any medical conditions or allergies before receiving the vaccine.

VAQTA 50 [iU]/mL may interact with certain medications or other vaccines. It is advisable to discuss your current medications and vaccination schedule with your healthcare provider to ensure safe administration. Avoid taking over-the-counter pain relievers or antipyretics unless advised by a healthcare professional.